The fair value estimate for Ionis Pharmaceuticals has shifted from US$96.73 to US$100.92, a modest reset that puts fresh numbers around the stock. This move comes during an active period of Street ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results